25
Views
26
CrossRef citations to date
0
Altmetric
Article

Extended haplotype analysis reveals an association of TNF polymorphisms with susceptibility to systemic lupus erythematosus beyond HLA‐DR3

, , , , , & show all
Pages 114-121 | Received 08 Sep 2004, Accepted 24 Nov 2004, Published online: 12 Jul 2009

References

  • Balkwill FR. Tumour necrosis factor. Br Med Bull 1989; 45:389–400.
  • Studnicka-Benke A, Steiner G, Petera P, Smolen JS. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythema-tosus. Br J Rheumatol 1996;35:1067–74.
  • Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 87:1233–7.
  • Jacob CO, McDevitt HO. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature 1988;331:356–8.
  • Prokunina L, Alarcon-Riquelme M. The genetic basis of systemic lupus erythematosus. Hum Mol Genet 2004;13:143–8.
  • Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA Al, B8, and DR3 alleles. J Exp Med 1993;177:557–60.
  • Carroll MC, Katzman P, Alicot EM, Koller BH, Geraghty DE, Orr HT, et al. Linkage map of the human major histocompat-ibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci USA 1987;84:8535–9.
  • Browning JL, Ngam-ek A, Lawton P, DeMarinis J, Tizard R, Chow EP, et al. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lympho-toxin on the cell surface. Cell 1993;72:847–56.
  • Wilson AG, di Giovine FS, Blakemore Al, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353.
  • Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195–9.
  • Kroeger KM, Carville KS, Abraham U. The -308 tumor necrosis factor-alpha promoter polymorphism effects tran-scription. Mol Immunol 1997;34: 391–9.
  • Webb GC, Chaplin DD. Genetic variability at the human tumor necrosis factor loci. J Immunol 1990;145:1278–85.
  • Abraham LJ, French MA, Dawkins RL. Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol 1993;92:14–18.
  • Nedospasov SA, Udalova IA, Kuprash DV, Turetskaya RL. DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/Iymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene. J Immunol 1991;147:1053–9.
  • Jongeneel CV, Briant L, Udalova IA, Sevin A, Nedospasov SA, Cambon-Thomsen A. Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. Proc Natl Acad Sci USA 1991;88:9717–21.
  • Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993;16:180–6.
  • Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaae H, Abbal M, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mono-nuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993;23:224–31.
  • Weissensteiner T, Lanchbury JS. TNFB polymorphisms characterize three lineages of TNF region microsatellite haplotypes. Immunogenetics 1997;47:6–16.
  • Bettinotti MP, Hartung K, Deicher H, Messer G, Keller E, Weiss EH, et al. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics 1993;37:449–54.
  • Wilson AG, Gordon C, di Giovine FS, de Vries N, van de Putte LB, Emery P, et al. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 1994;24:191–5.
  • Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes G, et al. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 1996;23:1725–8.
  • Kim TG, Kim HY, Lee SH, Cho CS, Park SH, Choi HB, et al. Systemic lupus erythematosus with nephritis is strongly associated with the TNFB*2 homozygote in the Korean population. Hum Immunol 1996;46:10–17.
  • Sturfelt G, Hellmer G, Truedsson L. TNF microsatellites in systemic lupus erythematosus - a high frequency of the TNFabc 2-3-1 haplotype in multicase SLE families. Lupus 1996;5: 618–22.
  • Chen CJ, Yen JH, Tsai WC, Wu CS, Chiang W, Tsai JJ, et al. The TNF2 allele does not contribute towards susceptibility to systemic lupus erythematosus. Immunol Lett 1997;55:1–3.
  • Lu LY, Ding WZ, Fici D, Deulofeut R, Cheng HH, Cheu CC, et al. Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in Taiwan. Arthritis Rheum 1997;40:1138–45.
  • Sullivan KE, Wooten C, Schmeckpeper BJ, Goldman D, Petri MA. A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum 1997;40:2207–11.
  • Hajeer AH, Worthington J, Davies EJ, Hillarby MC, Poulton K, Oilier WE. TNF microsatellite a2, b3 and d2 alleles are associated with systemic lupus erythematosus. Tissue Antigens 1997;49:222–7.
  • Tarassi K, Carthy D, Papasteriades C, Boki K, Nikolopoulou N, Carcassi C, et al. HLA-TNF haplotype heterogeneity in Greek SLE patients. Clin Exp Rheumatol 1998;16:66–8.
  • Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM, et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000;43:129–34.
  • Zuniga J, Vargas-Alarcon G, Hernandez-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, Granados J. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun 2001;2:363–6.
  • van der Linden MW, van der Slik AR, Zanelli E, Giphart MJ, Pieterman E, Schreuder GM, et al. Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus. Genes Immun 2001;2:373–80.
  • Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
  • Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study. Am J Cardiol 1992;70:733–7.
  • Higuchi R. Simple and rapid preparation of samples for PCR. In Ehrlich HA, editor. PCR-technology, principles and applica-tions for DNA amplification. New York: Stockton Press, 1989: 31–8.
  • Schluter B, Erren M, Schotte H, Junker R, Rust S, Assmann G. The mutagenically separated polymerase chain reaction is a rapid and reliable method for genotyping of the tumour necrosis factor-alpha promoter polymorphism (-308 G/A). Clin Chim Acta 2002;320:135–8.
  • Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978–89.
  • Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003;73:1162–9.
  • Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995;59:97–105.
  • Graham RR, Ortmann WA, Langefeld CD, Jawaheer D, Selby SA, Rodine PR, et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 2002;71:543–53.
  • Walport MJ, Black CM, Batchelor JR. The immunogenetics of SLE. Clin Rheum Dis 1982;8:3–21.
  • Hartung K, Fontana A, Klar M, Krippner H, Jorgens K, Lang B, et al. Association of class I, II, and III MHC gene products with systemic lupus erythematosus. Results of a Central European multicenter study. Rheumatol Int 1989;9:13–18.
  • So AK, Fielder AH, Warner CA, Isenberg DA, Batchelor JR, Walport MJ. DNA polymorphism of major histocompatibility complex class II and class III genes in systemic lupus erythematosus. Tissue Antigens 1990;35:144–7.
  • Bekker-Mendez C, Yamamoto-Furusho JK, Vargas-Alarcon G, Ize-Ludlow D, Alcocer-Varela J, Granados J. Haplotype distribution of class II MHC genes in Mexican patients with systemic lupus erythematosus. Scand J Rheumatol 1998; 27:373–6.
  • Zhang J, Ai R, Chow F. The polymorphisms of HLA-DR and TNF B loci in northern Chinese Han nationality and susceptibility to systemic lupus erythematosus. Chin Med Sci J 1997;12:107–10.
  • Walsh EC, Mather KA, Schaffner SF, Farwell L, Daly MJ, Patterson N, et al. An integrated haplotype map of the human major histocompatibility complex. Am J Hum Genet 2003; 73:580–90.
  • Gallagher G, Eskdale J, Oh HH, Richards SD, Campbell DA, Field M. Polymorphisms in the TNF gene cluster and MHC serotypes in the West of Scotland. Immunogenetics 1997; 45:188–94.
  • Santamaria P, Gehrz RC, Bryan MK, Barbosa JJ. Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic level. J Immunol 1989;143: 913–22.
  • Messer G, Spengler U, Jung MC, Honold G, Blomer K, Pape GR, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991;173:209–19.
  • Aringer M, Graninger WB, Steiner G, Smolen JS. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study. Arthritis Rheum 2004;50:3161–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.